More programs, more candles, more light.





Get the Flash Player to see this player.


Loading the player ...

A safety, Tolerability, and Efficacy Study of VC-01 Combination Product in Subjects with Type 1 Diabetes Mellitus

January 30, 2015
15 minutes
Kevin D'Amour, Robert Henry

 

Kevin D'Amour:

 

VP, Research & Chief Scientific Officer, ViaCyte.

 

Robert Henry:

 

Professor of Medicine, UC San Diego.

 

Chief, Section of Endocrinology, Metabolism & Diabetes, VA San Diego Healthcare System.